Found 47 matching trials
Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE) PHASE2 To evaluate the efficacy and safety of adjunctive pimavanserin compared wit...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis PHASE3 The purpose of this study is to evaluate the safety and efficacy of 34 mg p...
Show More Location
The First Affiliated Hospital of Anhui Medical University
Learn More & Join Trial
Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia PHASE3 To evaluate the long-term safety and tolerability of pimavanserin after 52 ...
Show More Location
171-Alea Research Institute
Learn More & Join Trial
Investigating the Neuropsychological Effects of 5-HT2a Antagonism NA Serotonin is an important chemical in the brain that helps control mood, sl...
Show More Location
Department of Psychiatry, University of Oxford
Learn More & Join Trial
Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder PHASE2 This Phase 2 study examines the safety, tolerability, and preliminary effic...
Show More Location
University of Kansas, Center for Research
Learn More & Join Trial
Pimavanserin for the Treatment of Irritability Associated With Autism Spectrum Disorder PHASE2 6-week, randomized, double-blind, fixed-dose, placebo-controlled, parallel ...
Show More Location
Southwest Autism Research & Resource Center
Learn More & Join Trial
Study to Evaluate Safety and Daytime Sedation in Subjects With Parkinson's Disease With Neuropsychiatric Symptoms Treated With Pimavanserin or Low-Dose Quetiapine PHASE2 This is a pilot study to explore the effects of pimavanserin and low-dose q...
Show More Location
Movement Disorders Center of Arizona
Learn More & Join Trial
Pimavanserin for Sleep in Parkinson Disease EARLY_PHASE1 This pilot, self-control study is for patients with Parkinson's Disease (PD...
Show More Location
SUNY Downstate Health Sciences University
Learn More & Join Trial
Comparing Antipsychotic Medications in LBD Over Time PHASE4 The primary objective of this study is to determine whether treatment with ...
Show More Location
University Health System
Learn More & Join Trial
ACP-103 to Treat Parkinson's Disease PHASE2 This study will evaluate the effects of an experimental drug called ACP-103...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial